{
  "DOI": "10.1007/s10689-006-0002-z",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-006-0002-z",
  "alternative-id": [
    "2"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Kram",
      "given": "Vardit",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Peretz",
      "given": "Tamar",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sagi",
      "given": "Michal",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2006,
        5,
        24
      ]
    ],
    "date-time": "2006-05-24T11:41:28Z",
    "timestamp": 1148470888000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        7
      ]
    ],
    "date-time": "2023-05-07T13:49:02Z",
    "timestamp": 1683467342000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        1,
        9
      ]
    ],
    "date-time": "2024-01-09T16:45:20Z",
    "timestamp": 1704818720744
  },
  "is-referenced-by-count": 25,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2006,
        5,
        25
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2006,
          12,
          6
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2006,
            5,
            25
          ]
        ],
        "date-time": "2006-05-25T00:00:00Z",
        "timestamp": 1148515200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-006-0002-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-006-0002-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-006-0002-z",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "327-335",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2006,
        5,
        25
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2006,
        5,
        25
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2006,
        12,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1056/NEJM199705153362001",
      "author": "JP Struewing",
      "doi-asserted-by": "crossref",
      "first-page": "1401",
      "journal-title": "N Engl J Med",
      "key": "2_CR1",
      "unstructured": "Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401–1408",
      "volume": "336",
      "year": "1997"
    },
    {
      "DOI": "10.1093/jnci/91.15.1310",
      "author": "The Breast Cancer Linkage Consortium",
      "doi-asserted-by": "crossref",
      "first-page": "1310",
      "journal-title": "J Natl Cancer Inst",
      "key": "2_CR2",
      "unstructured": "The Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310–1316",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1086/318787",
      "author": "HA Risch",
      "doi-asserted-by": "crossref",
      "first-page": "700",
      "journal-title": "Am J Hum Genet",
      "key": "2_CR3",
      "unstructured": "Risch HA, McLaughlin JR, Cole DE et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700–710",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1126/science.1088759",
      "author": "MC King",
      "doi-asserted-by": "crossref",
      "first-page": "643",
      "journal-title": "Science",
      "key": "2_CR4",
      "unstructured": "King MC, Marks JH, Mandell JB (2003) New York Breast Cancer Study Group. Breast cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643–646",
      "volume": "302",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0039-6109(05)70068-2",
      "author": "LC Hartmann",
      "doi-asserted-by": "crossref",
      "first-page": "1189",
      "journal-title": "Surg Clin North Am",
      "key": "2_CR5",
      "unstructured": "Hartmann LC, Sellers TA, Schaid DJ, et al (1999) Clinical options for women at high risk for breast cancer. Surg Clin North Am 79:1189–1206",
      "volume": "79",
      "year": "1999"
    },
    {
      "DOI": "10.1001/jama.1997.03540360065034",
      "author": "W Burke",
      "doi-asserted-by": "crossref",
      "first-page": "997",
      "journal-title": "JAMA",
      "key": "2_CR6",
      "unstructured": "Burke W, Daly M, Garber J et al (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2. JAMA 277:997–1003",
      "volume": "277",
      "year": "1997"
    },
    {
      "key": "2_CR7",
      "unstructured": "Seidman AD. BRCA1/2 mutations: implications for prognosis, treatment, outcome, prevention. American Society of Clinical Oncology 35th Annual Meeting. 1999"
    },
    {
      "DOI": "10.1056/NEJM199901143400201",
      "author": "LC Hartmann",
      "doi-asserted-by": "crossref",
      "first-page": "77",
      "journal-title": "N Engl J Med",
      "key": "2_CR8",
      "unstructured": "Hartmann LC, Schaid DJ, Woods JE et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77–84",
      "volume": "340",
      "year": "1999"
    },
    {
      "DOI": "10.1093/jnci/93.21.1633",
      "author": "LC Hartmann",
      "doi-asserted-by": "crossref",
      "first-page": "1633",
      "journal-title": "J Natl Cancer Inst",
      "key": "2_CR9",
      "unstructured": "Hartmann LC, Sellers TA, Schaid DJ et al (2001) Efficacy of prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633–1637",
      "volume": "93",
      "year": "2001"
    },
    {
      "DOI": "10.1056/NEJMoa012158",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1616",
      "journal-title": "N Engl J Med.",
      "key": "2_CR10",
      "unstructured": "Rebbeck TR, Lynch HT, Neuhausen SL et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 346:1616–1622",
      "volume": "346",
      "year": "2002"
    },
    {
      "DOI": "10.1056/NEJMoa020119",
      "author": "ND Kauff",
      "doi-asserted-by": "crossref",
      "first-page": "1609",
      "journal-title": "N Engl J Med",
      "key": "2_CR11",
      "unstructured": "Kauff ND, Satagopan JM, Robson ME et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609–1615",
      "volume": "346",
      "year": "2002"
    },
    {
      "DOI": "10.1056/NEJM199705153362022",
      "author": "D Schrag",
      "doi-asserted-by": "crossref",
      "first-page": "1465",
      "journal-title": "N Engl J Med",
      "key": "2_CR12",
      "unstructured": "Schrag D, Kuntz KM, Garber JE et al (1997) Decision analysis-effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 336: 1465–1471",
      "volume": "336",
      "year": "1997"
    },
    {
      "DOI": "10.1200/JCO.1998.16.3.979",
      "author": "VR Grann",
      "doi-asserted-by": "crossref",
      "first-page": "979",
      "journal-title": "J Clin Oncol",
      "key": "2_CR13",
      "unstructured": "Grann VR, Panageas KS, Whang W et al (1998) Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1 positive or BRCA2 positive patients. J Clin Oncol 16:979–985",
      "volume": "16",
      "year": "1998"
    },
    {
      "DOI": "10.1054/bjoc.1999.1086",
      "author": "TM Wagner",
      "doi-asserted-by": "crossref",
      "first-page": "1249",
      "journal-title": "Br J Cancer",
      "key": "2_CR14",
      "unstructured": "Wagner TM, Moslinger R, Langbauer G et al (2000) Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. Br J Cancer 82:1249–1253",
      "volume": "82",
      "year": "2000"
    },
    {
      "DOI": "10.1001/jama.284.3.319",
      "author": "MH Frost",
      "doi-asserted-by": "crossref",
      "first-page": "319",
      "journal-title": "JAMA",
      "key": "2_CR15",
      "unstructured": "Frost MH, Schaid DJ, Sellers TA et al (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284:319–324",
      "volume": "284",
      "year": "2000"
    },
    {
      "DOI": "10.1002/1099-1611(200011/12)9:6\u003c462::AID-PON485\u003e3.0.CO;2-J",
      "author": "P Hopwood",
      "doi-asserted-by": "crossref",
      "first-page": "462",
      "journal-title": "Psycho-Oncology",
      "key": "2_CR16",
      "unstructured": "Hopwood P, Lee A, Shenton A et al (2000) Clinical follow-up after bilateral risk reducing (ȁ8prophylacticȁ9) mastectomy: mental health and body image outcomes. Psycho-Oncology 9:462–472",
      "volume": "9",
      "year": "2000"
    },
    {
      "DOI": "10.1006/pmed.2000.0684",
      "author": "C Lerman",
      "doi-asserted-by": "crossref",
      "first-page": "75",
      "journal-title": "Prev Med",
      "key": "2_CR17",
      "unstructured": "Lerman C, Hughes C, Croyle RT et al (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med 31:75–80",
      "volume": "31",
      "year": "2000"
    },
    {
      "DOI": "10.1016/S0140-6736(00)02347-3",
      "author": "EJ Meijers-Heijboer",
      "doi-asserted-by": "crossref",
      "first-page": "2015",
      "journal-title": "Lancet",
      "key": "2_CR18",
      "unstructured": "Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT et al (2000) Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355:2015–2020",
      "volume": "355",
      "year": "2000"
    },
    {
      "DOI": "10.1177/0272989X0002000301",
      "author": "I Unic",
      "doi-asserted-by": "crossref",
      "first-page": "251",
      "journal-title": "Med Decis Making",
      "key": "2_CR19",
      "unstructured": "Unic I, Verhoef LC, Stalmeier PF et al (2000) Prophylactic mastectomy or screening in women suspected to have the BRCA1/BRCA2 mutation: a prospective pilot study of womenȁ9s treatment choices and medical decision-analytic recommendations. Med Decis Making 20:251–262",
      "volume": "20",
      "year": "2000"
    },
    {
      "author": "LS Di Prospero",
      "first-page": "1005",
      "journal-title": "CMAJ",
      "key": "2_CR20",
      "unstructured": "Di Prospero LS, Seminsky M, Honeyford J et al (2001) Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. CMAJ 164:1005–1009",
      "volume": "164",
      "year": "2001"
    },
    {
      "DOI": "10.1023/A:1013123915272",
      "author": "M Cappelli",
      "doi-asserted-by": "crossref",
      "first-page": "595",
      "journal-title": "Qual Life Res",
      "key": "2_CR21",
      "unstructured": "Cappelli M, Surh L, Humphreys L et al (2001) Measuring womenȁ9s preferences for breast cancer treatments and BRCA1/BRCA2 testing. Qual Life Res 10:595–607",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1002/1097-0142(20010815)92:4\u003c959::AID-CNCR1406\u003e3.0.CO;2-V",
      "author": "CM Julian-Reynier",
      "doi-asserted-by": "crossref",
      "first-page": "959",
      "journal-title": "Cancer",
      "key": "2_CR22",
      "unstructured": "Julian-Reynier CM, Bouchard LJ, Evans DG et al (2001) Womenȁ9s attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women. Cancer 92:959–968",
      "volume": "92",
      "year": "2001"
    },
    {
      "DOI": "10.1001/archsurg.138.12.1323",
      "author": "JN Weitzel",
      "doi-asserted-by": "crossref",
      "first-page": "1323",
      "journal-title": "Arch Surg",
      "key": "2_CR23",
      "unstructured": "Weitzel JN, McCaffrey SM, Nedelcu R et al (2003) Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg 138:1323–1328",
      "volume": "138",
      "year": "2003"
    },
    {
      "DOI": "10.1002/ajmg.a.10102",
      "author": "JR Botkin",
      "doi-asserted-by": "crossref",
      "first-page": "201",
      "journal-title": "Am J Med Genet",
      "key": "2_CR24",
      "unstructured": "Botkin JR, Smith KR, Croyle RT et al (2003) Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet 118A:201–209",
      "volume": "118A",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2002.20.5.1260",
      "author": "L Scheuer",
      "doi-asserted-by": "crossref",
      "first-page": "1260",
      "journal-title": "J Clin Oncol",
      "key": "2_CR25",
      "unstructured": "Scheuer L, Kauff N, Robson R et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260–1268",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2003.01.088",
      "author": "MD Schwartz",
      "doi-asserted-by": "crossref",
      "first-page": "4034",
      "journal-title": "J Clin Oncol",
      "key": "2_CR26",
      "unstructured": "Schwartz MD, Kaufman E, Penkin B et al (2003) Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA1 mutation testing. J Clin Oncol 21:4034–4041",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1023/A:1015269620265",
      "author": "LN Lodder",
      "doi-asserted-by": "crossref",
      "first-page": "97",
      "journal-title": "Breast Cancer Res Treat",
      "key": "2_CR27",
      "unstructured": "Lodder LN, Frets PG, Trijsburg RW et al (2002) One year follow up of women opting for presymptomatic testing for BRCA1 and BRCA1:emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 73:97–112",
      "volume": "73",
      "year": "2002"
    },
    {
      "DOI": "10.1158/1055-9965.1989.13.12",
      "author": "S Wainberg",
      "doi-asserted-by": "crossref",
      "first-page": "1989",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "2_CR28",
      "unstructured": "Wainberg S, Husted J (2004) Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiol Biomarkers Prev 13:1989–1995",
      "volume": "13",
      "year": "2004"
    },
    {
      "DOI": "10.1038/ng1095-198",
      "author": "JP Struewing",
      "doi-asserted-by": "crossref",
      "first-page": "198",
      "journal-title": "Nat Genet",
      "key": "2_CR29",
      "unstructured": "Struewing JP, Abeliovich D, Peretz T et al (1995) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198–200",
      "volume": "11",
      "year": "1995"
    },
    {
      "DOI": "10.1038/ng1096-188",
      "author": "C Oddoux",
      "doi-asserted-by": "crossref",
      "first-page": "188",
      "journal-title": "Nat Genet",
      "key": "2_CR30",
      "unstructured": "Oddoux C, Struewing JP, Clayton CM et al (1996) The carrier frequency of the BRCA2 617delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14:188–190",
      "volume": "14",
      "year": "1996"
    },
    {
      "DOI": "10.1038/ng1096-185",
      "author": "BB Roa",
      "doi-asserted-by": "crossref",
      "first-page": "185",
      "journal-title": "Nat Genet",
      "key": "2_CR31",
      "unstructured": "Roa BB, Boyd AA, Volcik K et al (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185–187",
      "volume": "14",
      "year": "1996"
    },
    {
      "author": "D Abeliovich",
      "first-page": "505",
      "journal-title": "Am J Hum Genet",
      "key": "2_CR32",
      "unstructured": "Abeliovich D, Kaduri L, Lerer I et al (1997) The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60:505–514",
      "volume": "60",
      "year": "1997"
    },
    {
      "DOI": "10.1006/gyno.1997.4844",
      "author": "U Beller",
      "doi-asserted-by": "crossref",
      "first-page": "123",
      "journal-title": "Gynecol Oncol",
      "key": "2_CR33",
      "unstructured": "Beller U, Halle D, Catane R et al (1997) High frequency of BRCA1 and BRCA2 mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history. Gynecol Oncol 67:123–126",
      "volume": "67",
      "year": "1997"
    },
    {
      "DOI": "10.1159/000484800",
      "author": "RB Bar-Sade",
      "doi-asserted-by": "crossref",
      "first-page": "413",
      "journal-title": "Eur J Human Gent",
      "key": "2_CR34",
      "unstructured": "Bar-Sade RB, Theodor L, Gak E, et al (1997) Could the 185delAG BRCA1 mutation be an ancient Jewish mutation? Eur J Human Gent 5:413–416",
      "volume": "5",
      "year": "1997"
    },
    {
      "DOI": "10.1086/301924",
      "author": "I Lerer",
      "doi-asserted-by": "crossref",
      "first-page": "272",
      "journal-title": "Am J Hum Gent",
      "key": "2_CR35",
      "unstructured": "Lerer I, Wang T, Peretz T et al (1998) The 8765delAG mutation in BRCA2 is common among Jews of Yemmenite extraction. Am J Hum Gent 63:272–274",
      "volume": "63",
      "year": "1998"
    },
    {
      "DOI": "10.1038/sj.bjc.6602207",
      "author": "M Watson",
      "doi-asserted-by": "crossref",
      "first-page": "1787",
      "journal-title": "Br J Cancer",
      "key": "2_CR36",
      "unstructured": "Watson M, Foster C, Eeles R et al (2004) Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer 91:1787–1794",
      "volume": "91",
      "year": "2004"
    },
    {
      "author": "HT Lynch",
      "first-page": "104",
      "journal-title": "Surgery",
      "key": "2_CR37",
      "unstructured": "Lynch HT, Organ CH Jr, Harris RE et al (1978) Familial cancer: implications for surgical management of high-risk patients. Review. Surgery 83:104–113",
      "volume": "83",
      "year": "1978"
    },
    {
      "DOI": "10.1002/1097-0142(19940715)74:2\u003c545::AID-CNCR2820740204\u003e3.0.CO;2-Q",
      "author": "HN Nguyen",
      "doi-asserted-by": "crossref",
      "first-page": "545",
      "journal-title": "Cancer",
      "key": "2_CR38",
      "unstructured": "Nguyen HN, Averette HE, Janicek M. (1994) Ovarian carcinoma. A review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer prevention Review. Cancer 74:545–555",
      "volume": "74",
      "year": "1994"
    },
    {
      "DOI": "10.1038/sj.ejhg.5200418",
      "author": "CM Julian-Reynier",
      "doi-asserted-by": "crossref",
      "first-page": "204",
      "journal-title": "Eur J Hum Genet",
      "key": "2_CR39",
      "unstructured": "Julian-Reynier CM, Eisinger F, Moatti JP et al (2000) Physiciansȁ9 attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines. Eur J Hum Genet 8:204–208",
      "volume": "8",
      "year": "2000"
    },
    {
      "DOI": "10.1200/JCO.1998.16.8.2868",
      "author": "G Geller",
      "doi-asserted-by": "crossref",
      "first-page": "2868",
      "journal-title": "J Clin Oncol",
      "key": "2_CR40",
      "unstructured": "Geller G, Bernhardt BA, Doksum T et al (1998) Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women?. J Clin Oncol 16:2868–2876",
      "volume": "16",
      "year": "1998"
    },
    {
      "DOI": "10.1200/JCO.2000.18.12.2484",
      "author": "ET Matloff",
      "doi-asserted-by": "crossref",
      "first-page": "2484",
      "journal-title": "J Clin Oncol",
      "key": "2_CR41",
      "unstructured": "Matloff ET, Shappel H, Brielly K et al (2000) What would you do? Specialistsȁ9 perspectives on cancer genetic testing, prophylactic surgery and insurance discrimination. J Clin Oncol 18:2484–2492",
      "volume": "18",
      "year": "2000"
    },
    {
      "DOI": "10.1089/10906570260199366",
      "author": "K Armstrong",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "journal-title": "Genetic testing",
      "key": "2_CR42",
      "unstructured": "Armstrong K, Stopper J, Calzone K et al (2002) What does my doctor think? Preferences for knowing the doctorȁ9s opinion among women considering clinical testing for BRCA1/2 mutations. Genetic testing 6:115–118",
      "volume": "6",
      "year": "2002"
    },
    {
      "DOI": "10.1136/jmg.37.11.866",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "866",
      "journal-title": "J Med Genet",
      "key": "2_CR43",
      "unstructured": "Metcalfe KA, Liede A, Hoodfar E et al (2000) An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counseling. J Med Genet 37:866–874",
      "volume": "37",
      "year": "2000"
    }
  ],
  "reference-count": 43,
  "references-count": 43,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-006-0002-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Acceptance of Preventive Surgeries by Israeli Women Who had Undergone BRCA Testing"
  ],
  "type": "journal-article",
  "volume": "5"
}